COVID-19 Vaccines COVID-19 MMR Vaccine Vaccine Development Vaccine Safety Covid Vaccines Respiratory Syncytial Virus (RSV) Covid-19 Vaccines COVID-19 Vaccine RSV Vaccine Preventive Medicine Respiratory Syncytial Virus RSV Vaccines mRNA Vaccines mRNA Technology Vaccine Access AstraZeneca Covid Vaccine Influenza Vaccine Infectious Diseases Biotech Industry Dengue Vaccines Childhood Vaccination Production Facilities Vaccine Skepticism Vaccines for Children Program Safety Public Health Policy Flu Vaccine Covid-19 Malaria Vaccine Coronavirus Vaccines Combination Vaccines Flu vaccine Healthcare Views Anti-Vaccine Conspiracy Theories Measles Malaria Immunization Schedule Coronavirus Vaccine Pharmaceutical Industry India Safety and Efficacy Covid-19 Vaccination Immunization Practices Child Immunization Child Health Vaccine Sales Tests Vaccine Requirements Advisory Committees Nasal Spray Vaccine Availability Flu Vaccines COVID-19 Vaccination Biotechnology Operation Warp Speed Skin Cancer Clinical Trials Adverse Reactions Comparison Studies mRNA-1083 Combined Vaccines Production Capacity Pneumococcal Vaccines HPV Vaccine Dengue Vaccine Respiratory Diseases H5N1 Vaccine mRNA-based Vaccines Mpox Vaccine Types of Vaccines Vaccine Effectiveness
The company credits an expanded late-stage pipeline for the higher forecast.
